Evidence map›Paper›PMID 26027496›Full record

ArticleAmerican journal of human genetics2015

Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.

Craig F Munns, Somayyeh Fahiminiya, Nabin Poudel, Maria Cristina Munteanu, Jacek Majewski, David O Sillence, Jordan P Metcalf, Andrew Biggin, Francis Glorieux, François Fassier and 2 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Spondylo-ocular Syndrome Due to a Novel Variant inJournal of pediatric genetics · 2022
    Article
  19. Article
  20. MutantFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Craig F MunnsInstitute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Somayyeh FahiminiyaDepartment of Human Genetics, Faculty of Medicine, McGill University and Genome Quebec Innovation Center, Montréal, QC H3A 1B1, Canada.
Nabin PoudelDepartment of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Maria Cristina MunteanuDepartment of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Jacek MajewskiDepartment of Human Genetics, Faculty of Medicine, McGill University and Genome Quebec Innovation Center, Montréal, QC H3A 1B1, Canada.
David O SillenceDiscipline of Genetic Medicine, The Children's Hospital at Westmead Clinical School, Sydney Medicine, Westmead, NSW 2145, Australia.
Jordan P MetcalfDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73126, USA.
Andrew BigginInstitute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Francis GlorieuxShriners Hospital for Children, Montréal, QC H3G 1A6, Canada.
François FassierShriners Hospital for Children, Montréal, QC H3G 1A6, Canada.
Frank RauchShriners Hospital for Children, Montréal, QC H3G 1A6, Canada.
Myron E HinsdaleDepartment of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078, USA; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73126, USA. Electronic address: myron.hinsdale@okstate.edu.
Children's Hospital at Westmead · AUOklahoma State University · USShriners Hospitals for Children - Canada · CAMcGill University and Génome Québec Innovation Centre · CAUniversity of Oklahoma Health Sciences Center · US

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2004 to 2023
$56.2M
ZFC3H1 Regulation of Host Defense and Influenza A Virus PathogenesisP20GM103648 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI LIU, LIN · 2013 to 2022
$22.3M
Extracellular determinants of polycystic kidney disease severityR01DK087989 · NIDDK · OKLAHOMA STATE UNIVERSITY STILLWATER · PI HINSDALE, MYRON E · 2010 to 2014
$1.6M
Antiviral Immunosuppression by Cigarette SmokeI01BX001937 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI METCALF, JORDAN PATRICK · 2015 to 2019
–
BLRD VA I01 BX001937NIAID NIH HHS AI062629NIAID NIH HHS U19 AI062629NIDDK NIH HHS DK087989NIDDK NIH HHS R01 DK087989NIGMS NIH HHS GM103648NIGMS NIH HHS P20 GM103648
6 · The paper itself

Abstract

Heparan and chondroitin/dermatan sulfated proteoglycans have a wide range of roles in cellular and tissue homeostasis including growth factor function, morphogen gradient formation, and co-receptor activity. Proteoglycan assembly initiates with a xylose monosaccharide covalently attached by either xylosyltransferase I or II. Three individuals from two families were found that exhibited similar phenotypes. The index case subjects were two brothers, individuals 1 and 2, who presented with osteoporosis, cataracts, sensorineural hearing loss, and mild learning defects. Whole exome sequence analyses showed that both individuals had a homozygous c.692dup mutation (GenBank: NM_022167.3) in the xylosyltransferase II locus (XYLT2) (MIM: 608125), causing reduced XYLT2 mRNA and low circulating xylosyltransferase (XylT) activity. In an unrelated boy (individual 3) from the second family, we noted low serum XylT activity. Sanger sequencing of XYLT2 in this individual revealed a c.520del mutation in exon 2 that resulted in a frameshift and premature stop codon (p.Ala174Profs(∗)35). Fibroblasts from individuals 1 and 2 showed a range of defects including reduced XylT activity, GAG incorporation of (35)SO4, and heparan sulfate proteoglycan assembly. These studies demonstrate that human XylT2 deficiency results in vertebral compression fractures, sensorineural hearing loss, eye defects, and heart defects, a phenotype that is similar to the autosomal-recessive disorder spondylo-ocular syndrome of unknown cause. This phenotype is different from what has been reported in individuals with other linker enzyme deficiencies. These studies illustrate that the cells of the lens, retina, heart muscle, inner ear, and bone are dependent on XylT2 for proteoglycan assembly in humans.

Indexed as

HomozygoteBase SequenceCataractCraniofacial AbnormalitiesDiphosphonatesExomeEye Diseases, HereditaryFrameshift MutationHearing DisordersHumansImmunohistochemistryMaleMolecular Sequence DataOsteochondrodysplasiasOsteoporosisPamidronateDiphosphonatesPamidronatePentosyltransferasesUDP Xylose-Protein Xylosyltransferase

Identifiers

PMID26027496
PMCPMC4457947
OpenAlexW1489232513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.